US Patent Issued to NANJING IMMUNOPHAGE BIOTECH on Oct. 14 for "Anti-ROR1 antibodies and preparation method and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,795, issued on Oct. 14, was assigned to NANJING IMMUNOPHAGE BIOTECH Co. LTD. (Nanjing, China).

"Anti-ROR1 antibodies and preparation method and uses thereof" was invented by Guohuang Fan (Shanghai) and Jianfei Wang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-ROR1 antibodies and to methods of using anti-ROR1 antibodies. The anti-ROR1 antibodies described herein are useful for the diagnosis and treatment of diseases, such as various cancers, associated with aberrant expression of ROR1."

The patent was filed on Sept. 24, 2020, under Application No. 17/763,660.

*For further information, including imag...